drugset / Trial / NCT06801509
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine
RandomizedParallel-groupDouble-blindPrevention
Summary
The purposes of the study are to evaluate the Safety, Tolerability, and Immunogenicity of different dose levels of recombinant herpes zoster vaccine with 2 doses 60 days apart in healthy subjects aged 40 years and older.
Timeline
- Start
- 2025-02-15
- Primary completion
- 2025-11-10
- Completion
- 2027-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ganwei | Traditional medicine (herbal / TCM) | 0.5 ml | Subcutaneous |
| Subject | SCTV04C | Vaccine | — | Intramuscular |
| Comparator | VARICELLA ZOSTER VIRUS ENVELOPE GLYCOPROTEIN E | Vaccine | 50 ug | Intramuscular |